DateInvalid Date
Read Time1 min
FDA Approves First Gene Therapy for Deafness
The Food and Drug Administration has granted approval for the inaugural gene therapy aimed at restoring hearing in individuals born with specific forms of deafness. This monumental decision, while initially targeting a rare genetic condition, marks a significant stride in the ongoing efforts to combat hearing loss and opens new avenues for therapeutic interventions.

By Michele NorrisApr 23, 2026
Elon Musk's SpaceX Poised for Public Offering with Unique Executive Compensation
Elon Musk is preparing to take SpaceX public, adopting an unconventional executive compensation strategy that grants him significant control. This move echoes his earlier intentions for Tesla, where his ownership stake currently offers less direct authority. The impending IPO is attracting substantial investor interest, with predictions pointing to a valuation that could set new records.

By Ramit SethiApr 23, 2026
SanDisk Stock Experiences Downturn from Peak Wednesday Valuation
SanDisk shares are declining following record highs, influenced by broader market corrections and geopolitical tensions. Despite this, strong data center demand continues to underpin the company's long-term outlook, with analysts maintaining positive ratings ahead of upcoming earnings.

By Dave RamseyApr 23, 2026
Cryptocurrency Markets in Sideways Trend Amid Geopolitical Tensions
Major cryptocurrencies like Bitcoin, Ethereum, XRP, and Dogecoin are exhibiting sideways trading patterns. This stagnation is occurring as geopolitical developments, particularly Iran's peace initiatives, face difficulties, influencing broader market sentiment. Bitcoin has managed to hold steady around the $78,000 mark, demonstrating resilience in the face of ongoing global uncertainties.

By Natalie PaceApr 23, 2026
Helen of Troy Stock Soars on Robust Earnings and Positive Forecast
Helen of Troy's stock experienced a significant surge following an impressive earnings report that surpassed analyst expectations. Despite ongoing challenges in certain market segments, the company's strong performance and optimistic outlook have triggered a short squeeze, driving shares upward. This rebound signifies a pivotal moment for the consumer products giant as it pivots towards a growth-centric strategy.

By Natalie PaceApr 23, 2026